Clinical Trial Update: Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial evaluating a dual-vector base editor for CHD3-R1025W mutation, with recruitment ongoing for developmental delay and inte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental Delay
• Intellectual Disability

Snippet

Sponsor: Yongguo Yu | Conditions: Developmental Delay Disorder, Intellectual Disability | EARLY_Phase 1 | Status: RECRUITING